PTPI
Vanguard Group’s Petros Pharmaceuticals PTPI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31,811
| Closed | -$2.2K | – | 4317 |
|
|
2025
Q1 | $2.2K | Hold |
31,811
| – | – | ﹤0.01% | 4279 |
|
|
2024
Q4 | $12.5K | Hold |
31,811
| – | – | ﹤0.01% | 4279 |
|
|
2024
Q3 | $11.4K | Hold |
31,811
| – | – | ﹤0.01% | 4321 |
|
|
2024
Q2 | $14.6K | Hold |
31,811
| – | – | ﹤0.01% | 4375 |
|
|
2024
Q1 | $47.1K | Hold |
31,811
| – | – | ﹤0.01% | 4323 |
|
|
2023
Q4 | $44.9K | Hold |
31,811
| – | – | ﹤0.01% | 4381 |
|
|
2023
Q3 | $55K | Hold |
31,811
| – | – | ﹤0.01% | 4400 |
|
|
2023
Q2 | $64.6K | Buy |
31,811
+20,922
| +192% | +$42.5K | ﹤0.01% | 4431 |
|
|
2023
Q1 | $15.2K | Sell |
10,889
-8,902
| -45% | -$12.4K | ﹤0.01% | 4538 |
|
|
2022
Q4 | $46.1K | Sell |
19,791
-236,123
| -92% | -$550K | ﹤0.01% | 4452 |
|
|
2022
Q3 | $131K | Buy |
255,914
+136,773
| +115% | +$70K | ﹤0.01% | 4470 |
|
|
2022
Q2 | $100K | Buy |
119,141
+5,318
| +5% | +$4.46K | ﹤0.01% | 4549 |
|
|
2022
Q1 | $178K | Sell |
113,823
-37,424
| -25% | -$58.5K | ﹤0.01% | 4551 |
|
|
2021
Q4 | $504K | Buy |
151,247
+41,534
| +38% | +$138K | ﹤0.01% | 4432 |
|
|
2021
Q3 | $219K | Buy |
109,713
+2,213
| +2% | +$4.42K | ﹤0.01% | 4479 |
|
|
2021
Q2 | $336K | Buy |
107,500
+18,796
| +21% | +$58.7K | ﹤0.01% | 4322 |
|
|
2021
Q1 | $331K | Buy |
88,704
+26,628
| +43% | +$99.4K | ﹤0.01% | 4198 |
|
|
2020
Q4 | $273K | Buy |
+62,076
| New | +$273K | ﹤0.01% | 4054 |
|